Overview

Safety Study of the VEGA UV-A System to Treat Keratoconus

Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL), when used to treat keratoconus.
Phase:
Phase 3
Details
Lead Sponsor:
Topcon Medical Systems, Inc.
Treatments:
Riboflavin